Comparative efficacy of fexofenadine and levocetirizine in chronic idiopathic urticaria [3]

Indian Journal of Dermatology

Volumn 52, Issue 4, 2007, Pages 212-213

  Godse, K ^a   Jain, A ^b   Pharande, P ^b  

^a Terna Dental College and Hospital   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FEXOFENADINE; LEVOCETIRIZINE; PLACEBO;

ADOLESCENT; ADULT; AGED; BLOOD CELL COUNT; CHRONIC IDIOPATHIC URTICARIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; LETTER; MALE; MORNING DOSAGE; MULTICENTER STUDY; PATIENT ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URTICARIA;

EID: 37849027632     PISSN: 00195154     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5154.37733     Document Type: Letter

References (5)

1. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: A single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002;110:484-8.
2. Paul E, Berth Jones J, Ortonne JP. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo controlled parallel group, close ranging study. J Dermatol Treatment 1998;9:143-9.
3. Walsh GM. Levocetirizine: An update. Curr Med Chem 2006;13:2711-5.
4. Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 2006;45:469-74.
5. Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999;104:1071-8.